MTOR

There are 1,492 papers on MTOR in aging research: 63 trials and 63 observational studies in people, 775 in animals, 220 in cells, 342 reviews.

Gene

1,492 papers study it186 findings

HGNCMGINCBI GeneTaxon

26 new papers in 30 daysSee all 1,492 papers on MTOR

At a glance

Hypomorphic MTOR alleles extend mouse lifespan, while MTOR overexpression extends lifespan in CG7156-knockdown flies. Independent labs reproduce mTOR-driven senescence in human cells and reduced mTOR signaling with caloric restriction in mice, though restriction results also point the other way. Some registered trials across its uses remain without posted results or citing papers over a year after ending.

186 findings in 148 papers from 2009 to 2026, 13 of them since April 2026

Independent labs found the same change in cells, worms or flies, mice and people. 273 independent labs in 41 countries; 107 trials, 28 with no results posted.

“by immunohistochemical analysis, we documented altered expression of mTOR and its well-characterized downstream substrates”
Targeting PI3K/AKT/mTOR Pathway Exerts Inhibitory Effects on Endothelial Cells from Generalized Lymphatic AnomalyCells2026doi:10.3390/cells15201860

22 of its findings point the other way.

Cells, worms or flies, mice and humans: replicated by independent labs.
  • 273 independent labs in 41 countries
  • 22 findings against
  • 107 trials, 28 with no results posted
  • Funders: National Institutes of Health and others
  • 46 of 602 findings with company ties
  • 102 of 107 trials sponsored by developers of drugs aimed at it
  • Human trial63
  • Humans63
  • Animals739
  • Model organisms36
  • Cells220
  • In silico21

Interventions

45

Rapamycin

downin reviews6downin silico1

7 studies
  1. Rapamycin inhibits MTOR (at ultra-low dose).

    “ultra-low dose rapamycin provides mTOR inhibition”

    Reviewat ultra-low doseultra-low dose

    Autophagy Enhancement with Spermidine and Rapamycin Microdosing

    Zenodo (CERN European Organization for Nuclear Research)Preprint

  2. Rapamycin inhibits MTOR in silico (predicted in silico, validated against documented mechanism).

    “the model correctly predicted rapamycin's inhibition of mTOR and metformin's activation of AMPK.”

    In silicopredicted in silico, validated against documented mechanism

    In Silico Assessment of Potential Geroprotectors: From Separate Endpoints to Complex Pharmacotherapeutic Effects

    International journal of molecular sciences

  3. Rapamycin inhibits MTOR.

    “Rapamycin and its analogs (everolimus, temsirolimus, ridaforolimus) inhibit the mammalian target of rapamycin (mTOR) kinase by binding to FK506-binding proteins (FKBP)”

    Review

    Why Is Rapamycin Not a Rapalog?

    Gerontology

  4. Rapamycin inhibits MTOR.

    “its immunosuppressant effects that are mediated by its inhibition of the mechanistic target of rapamycin (mTOR)”

    Review

    Challenges of rapamycin repurposing as a potential therapeutic candidate for COVID-19: implications for skeletal muscle metabolic health in older persons

    American journal of physiology. Endocrinology and metabolism

  5. Rapamycin inhibits MTOR.

    “targeted therapy like mTOR inhibitors such as Rapamycin and selective PI3Kδ inhibitors”

    Review

    An updated review on activated PI3 kinase delta syndrome (APDS)

    Genes & diseases

  6. Rapamycin inhibits MTOR.

    “Rapamycin is a potent and selective inhibitor of the mechanistic target of rapamycin (mTOR) protein kinase”

    Review

    Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond

    Cold Spring Harbor perspectives in medicine

  7. Rapamycin inhibits MTOR.

    “By inhibiting the activity of mammalian target of rapamycin (mTOR)”

    Review

    Fighting neurodegeneration with rapamycin: mechanistic insights

    Nature reviews. Neuroscience

More on Rapamycin

Leucine

upin humans1upin mice1upin reviews1

3 studies
  1. Leucine activates MTOR.

    “the discovery of the unique role of leucine for the activation of the mTOR signal complex for the initiation of MPS”

    Review

    Impacts of protein quantity and distribution on body composition

    Frontiers in nutrition

  2. Leucine activates MTOR in humans.

    “l-leucine activates TOR to initiate protein synthesis in the skeletal muscle.”

    Reviewskeletal muscle

    The effects of glucagon and the target of rapamycin (TOR) on skeletal muscle protein synthesis and age-dependent sarcopenia in humans

    Clinical nutrition ESPEN

  3. Leucine activates MTOR in 13-month-old mice.

    “both 8 weeks of leucine supplementation and aerobic training elevated the activity of mTOR”

    Animalsin 13-month-old micechow diet with 5% leucineskeletal muscle5% leucine in chow8 weeks

    Hypertrophy-Promoting Effects of Leucine Supplementation and Moderate Intensity Aerobic Exercise in Pre-Senescent Mice

    Nutrients

More on Leucine

Dietary restriction

downin C. japonica2no changein rats1

3 studies
  1. Dietary restriction decreases MTOR in C. japonica (sex difference, females).

    “DR downregulated mTOR expression more in females than in males.”

    Animalssex difference, femalesliverfemales

    Dietary restriction reveals sex-specific expression of the mTOR pathway genes in Japanese quails

    Scientific reports

  2. Dietary restriction decreases MTOR in C. japonica.

    “dietary restriction led to decreased expression of mTOR and insulin-like growth factor 1 (IGF1)”

    Animals2 weeks

    Dietary restriction and life-history trade-offs: insights into mTOR pathway regulation and reproductive investment in Japanese quail

    The Journal of experimental biology

  3. Dietary restriction showed no clear effect on MTOR in rats (IPDR and PNDR groups).

    “IPDR and PNDR reduced skeletal muscle mass but did not decrease mTOR.”

    AnimalsIPDR and PNDR groupsskeletal muscle

    Early dietary restriction in rats alters skeletal muscle tuberous sclerosis complex, ribosomal s6 and mitogen-activated protein kinase

    Nutrition research (New York, N.Y.)

More on Dietary restriction

Rapamycin analog

downin human cells1downin yeast cells1

1 study
  1. Rapamycin analog inhibits MTOR in human cells (restricted to cells expressing mutant FKBP12).

    “selective mTOR inhibition can be achieved in Saccharomyces cerevisiae and human cells”

    Cellsrestricted to cells expressing mutant FKBP12

    Tissue-restricted inhibition of mTOR using chemical genetics

    Proceedings of the National Academy of Sciences of the United States of America

  2. Rapamycin analog inhibits MTOR in yeast cells (restricted to cells expressing mutant FKBP12).

    “selective mTOR inhibition can be achieved in Saccharomyces cerevisiae and human cells”

    Cellsrestricted to cells expressing mutant FKBP12

    Tissue-restricted inhibition of mTOR using chemical genetics

    Proceedings of the National Academy of Sciences of the United States of America

More on Rapamycin analog

Time-restricted feeding

upin humans1

1 study
  1. Time-restricted feeding increases MTOR in humans (evening).

    “and also increased the expression of MTOR (p = 0.007)”

    Human trialeveningearly (8 am–2 pm eating window)whole blood4-dayn = 11

    Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans

    Nutrients

  2. Time-restricted feeding increases MTOR in humans (9 ± 3%).

    “CLOCK and PER2 were unaffected at both times of day (p ≥ 0.32). eTRF also increased levels of SIRT1 (10 ± 3%; p = 0.004) and LC3A (22 ± 5%; p = 0.001) in the morning and increased levels of MTOR (9 ± 3%; p = 0.007) in the evening.”

    Human trial4 daysn = 8

    Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans

    Nutrients

More on Time-restricted feeding

Learning

no changein zebrafish1upin zebrafish1

1 study
  1. Learning showed no clear effect on MTOR in zebrafish (young animals).

    “In younger animals, this increase in activation did not occur”

    Animalsyoung animalsbrain

    Effects of learning on mTOR pathway gene expression in the brain of zebrafish (Danio rerio) of different ages

    Experimental gerontology

  2. Learning activates MTOR in zebrafish (old animals, early phase of memory consolidation).

    “TOR activation in old animals occurs in the early phase of consolidation”

    Animalsold animals, early phase of memory consolidationbrain

    Effects of learning on mTOR pathway gene expression in the brain of zebrafish (Danio rerio) of different ages

    Experimental gerontology

More on Learning

Safflower yellow

downin rats1

1 study
  1. Safflower yellow inhibits MTOR in rats (sevoflurane-induced cognitive impairment).

    “decreased p-mTOR/mTOR”

    Animalssevoflurane-induced cognitive impairmenthippocampusmales

    Safflower yellow investigates AMPK/mTOR-mediated autophagy to mitigate sevoflurane-induced neuroinflammation and cognitive dysfunction

    Journal of Radiation Research and Applied Sciences

More on Safflower yellow

Cedrus deodara flavonoids

downin mice1

1 study
  1. Cedrus deodara flavonoids decrease MTOR in mice (gene expression measured by RT-qPCR).

    “qPCR confirming upregulated Sirt1-PGC-1α and downregulated mTOR”

    Animalsgene expression measured by RT-qPCRtotal flavonoid extract14 days

    Green Extraction of Flavonoids from Cedrus deodara Pollen with Deep Eutectic Solvents and Their Potential Anti-Senescence Properties

    Research SquarePreprint

More on Cedrus deodara flavonoids

Aerobic training

upin rats1

1 study
  1. Aerobic training increases MTOR in rats (expression measured by qRT-PCR; regardless of age) (main effect of Exercise p < 0.001).

    “mTOR expression increased with exercise regardless of age (main effect of Exercise, p < 0.001).”

    Animalsexpression measured by qRT-PCR; regardless of agerunning-wheel trainingmyocardium8 weeksmalesn = 48

    Age-dependent effects of aerobic training on cardiac expression of Akt1, mTOR, and CITED4 in immature, young-adult, and middle-aged rat myocardium

    European journal of applied physiology

More on Aerobic training

Kun-ling wan formula

downin mouse cells1

1 study
  1. Kun-ling wan formula inhibits MTOR in mouse cells during C3H10T1/2 cell differentiation; reversible by leucine.

    “KLW inhibited mTOR/S6K phosphorylation during differentiation”

    Cellsduring C3H10T1/2 cell differentiation; reversible by leucine

    Kun-Ling Wan Formula Ameliorates Postmenopausal Osteoporosis and Adipose Accumulation by Suppressing mTOR Signaling in Mesenchymal Stem Cells

    Pharmaceuticals (Basel, Switzerland)

More on Kun-ling wan formula

Aerobic exercise

downin humans1

1 study
  1. Aerobic exercise decreases MTOR in humans.

    “In this study, it was found that the IFG, EXG, and IFEXG interventions all significantly reduced mTOR levels.”

    Human trialtwo weeksn = 10

    Combined Aerobic Exercise with Intermittent Fasting Is Effective for Reducing mTOR and Bcl-2 Levels in Obese Females

    Sports (Basel, Switzerland)

More on Aerobic exercise

Intermittent fasting

downin humans1

1 study
  1. Intermittent fasting decreases MTOR in humans.

    “In this study, it was found that the IFG, EXG, and IFEXG interventions all significantly reduced mTOR levels.”

    Human trialtwo weeksn = 10

    Combined Aerobic Exercise with Intermittent Fasting Is Effective for Reducing mTOR and Bcl-2 Levels in Obese Females

    Sports (Basel, Switzerland)

More on Intermittent fasting

Aerobic exercise + intermittent fasting

downin humans1

1 study
  1. Aerobic exercise + intermittent fasting decreases MTOR in humans.

    “When reviewing the pre–post mTOR levels of the three intervention groups, IFEXG had a greater reduction than IFG and EXG.”

    Human trialtwo weeksn = 10

    Combined Aerobic Exercise with Intermittent Fasting Is Effective for Reducing mTOR and Bcl-2 Levels in Obese Females

    Sports (Basel, Switzerland)

More on Aerobic exercise + intermittent fasting

Exercise

downin humans1

1 study
  1. Exercise decreases MTOR in humans.

    “A statistically significant decrease was found in the relative abundance of mTOR (z = −2.533; p = 0.011, d = 0.58540).”

    Human triallymphocytes8-weekmalesn = 9

    The Impact of 8 Weeks of Combined Physical Exercise Training on SIRT3 and mTOR in Lymphocytes, and on Lipid Peroxidation

    Healthcare (Basel, Switzerland)

More on Exercise

Collagen protein hydrolysate + milk protein

upin humans1

1 study
  1. Collagen protein hydrolysate + milk protein activates MTOR in humans (FED leg, at 2 h).

    “In the FED leg, both MP and CP+MP significantly elevated mTOR activation at 2 h (P < 0.05), with the response to CP+MP being significantly greater (P < 0.05) ( A).”

    Human trialFED leg, at 2 hmalesn = 8

    A collagen hydrolysate/milk protein-blend stimulates muscle anabolism equivalently to an isoenergetic milk protein-blend containing a greater quantity of essential amino acids in older men

    Clinical nutrition (Edinburgh, Scotland)

More on Collagen protein hydrolysate + milk protein

All 45

Effects

66

Cellular senescence

upin human cells3is required forin human cells2upin cells1upin mice1+2

9 studies
  1. MTOR induces cellular senescence in human cells (LAM models).

    “LAM models induce mTOR dependent senescence in alveolar type 2 cell organoids in vitro and in vivo.”

    CellsLAM modelsalveolar type 2 cell

    mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence impeding lung repair in lymphangioleiomyomatosis

    Nature communications

  2. MTOR increases cellular senescence (hyperactivation of mTOR).

    “hyperactivation of mTOR promotes cellular senescence and disrupts decidualization”

    Reviewhyperactivation of mTORendometrium

    Regulatory Interplay of p53, AMPK, and mTOR in Decidualization: Implications for Reproductive Competence and Cancer Biology

    Reproductive sciences (Thousand Oaks, Calif.)

  3. MTOR is required for cellular senescence in human cells during establishment of the senescent state.

    “This reactivation of mTOR, which is critical for establishing the senescent state”

    Cellsduring establishment of the senescent statedermal fibroblast

    TFEB Orchestrates Stress Recovery and Paves the Way for Senescence Induction in Human Dermal Fibroblasts

    Aging cell

  4. MTOR increases cellular senescence in mice (shown by endothelial cell-specific deletion).

    “Improvement in arterial function in old mice was concomitant with reductions in arterial cellular senescence, inflammation, and oxidative stress.”

    Animalsshown by endothelial cell-specific deletionartery

    Endothelial cell-specific reduction in mTOR ameliorates age-related arterial and metabolic dysfunction

    Aging cell

  5. MTOR mediates cellular senescence (cardiovascular disorders).

    “we highlight the targets (SIRT1 and mTOR) that regulating cellular senescence in cardiovascular disorders”

    Reviewcardiovascular disorders

    Cellular Senescence in Cardiovascular Diseases: A Systematic Review

    Aging and disease

  6. MTOR is required for cellular senescence in human cells (at least partially; together with DNA-damage response signaling).

    “Astrocyte senescence was at least partially depending on active mechanistic-target-of-rapamycin (mTOR) and DNA-damage response signaling”

    Cellsat least partially; together with DNA-damage response signalingastrocyte

    Unique signatures of stress-induced senescent human astrocytes

    Experimental neurology

  7. MTOR increases cellular senescence in cells (shown by inhibition; blocking mTOR prevented induction of senescence).

    “restoration of mitophagy, either by overexpression of parkin or inhibition of mTOR, prevents mitochondrial dysfunction and induction of senescence”

    Cellsshown by inhibition; blocking mTOR prevented induction of senescencecardiomyocytes

    Monoamine oxidase-A is a novel driver of stress-induced premature senescence through inhibition of parkin-mediated mitophagy

    Aging cell

  8. MTOR increases cellular senescence in human cells (shown by inhibition in OSKM-expressing primary human fibroblasts).

    “mTOR inhibition blunts the induction of cyclin-dependent kinase (CDK) inhibitors (CDKIs), including p16INK4a, p21CIP1, and p15INK4b, preventing OSKM-induced senescence.”

    Cellsshown by inhibition in OSKM-expressing primary human fibroblasts

    Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence

    Genes & development

  9. MTOR increases cellular senescence in human cells (shown by silencing MTOR expression in the extended-passaging model).

    “Rapamycin and silencing of mTOR expression inhibited replicative senescence in VSMCs”

    Cellsshown by silencing MTOR expression in the extended-passaging modelvascular smooth muscle cell

    The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs

    Molecular and cellular biochemistry

More on Cellular senescence

Autophagy

downin mice2downin cells1mediatesin mouse cells1downin reviews1

5 studies
  1. MTOR inhibits autophagy in mice (aged mice).

    “Increased mTOR expression in aged mice further suggested mTOR-driven autophagy inhibition.”

    Animalsaged mice

    Sex-specific effects of acetylation on tauopathy in aging htau mice

    Scientific reports

  2. MTOR mediates autophagy in mouse cells (downstream of SIRT2 in D-galactose-treated HT-22 cells).

    “These effects were abolished by mTOR activation, confirming mTOR as a downstream mediator of SIRT2.”

    Cellsdownstream of SIRT2 in D-galactose-treated HT-22 cells

    Inhibition of Sirtuin 2 enhances autophagy and restores neuronal function in aged hippocampal neurons

    Brain research bulletin

  3. MTOR inhibits autophagy.

    “mammalian target of rapamycin complex 1 (mTORC1) may leave anti-aging impacts by robustly inhibiting autophagy”

    Review

    mTOR signaling and Alzheimer's disease: What we know and where we are?

    CNS neuroscience & therapeutics

  4. MTOR inhibits autophagy in mice (mTOR overactivation in Zmpste24-/- mice; reducing mTOR partially restores autophagy).

    “mTOR inhibition partially restores autophagy and S6K1 activity.”

    AnimalsmTOR overactivation in Zmpste24-/- mice; reducing mTOR partially restores autophagy

    Accumulation of prelamin A induces premature aging through mTOR overactivation

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

  5. MTOR inhibits autophagy in cells (via ULK1 phosphorylation at S757).

    “phosphorylates ULK1 at S757 to further inactivate ULK1, LC3A and autophagy”

    Cellsvia ULK1 phosphorylation at S757

    Involvement of mTOR-autophagy in the selection of primitive mesenchymal stem cells in chitosan film 3-dimensional culture

    Scientific reports

More on Autophagy

Lifespan

downin mice2upin flies1mediatesin reviews1−20% median survival in mtor(δ/δ) mice

4 studies
  1. MTOR extends lifespan in flies (overexpression in CG7156-knockdown flies).

    “Overexpression of mTOR in this model improved motor function and lifespan.”

    Model organismsoverexpression in CG7156-knockdown flies

    Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder

    American journal of human genetics

  2. MTOR shortens lifespan in mice (shown by genetic reduction in mice carrying two copies of the human LMNA G608G BAC).

    “genetic reduction of the mechanistic target of rapamycin (mTOR) significantly extends lifespan in these mice”

    Animalsshown by genetic reduction in mice carrying two copies of the human LMNA G608G BAC

    Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome

    Aging cell

  3. MTOR mediates lifespan under dietary restriction.

    “mTOR is emerging as the most robust mediator of the protective effects of various forms of dietary restriction, which has been shown to extend lifespan and slow the onset of age-related diseases across species”

    Reviewunder dietary restriction

    mTOR and Aging: An Old Fashioned Dress

    International journal of molecular sciences

  4. MTOR shortens lifespan in mice (shown by hypomorphic mTOR(Δ/Δ) alleles with about 25% of wild-type expression) (approximately 20% increase in median survival in mTOR(Δ/Δ) mice).

    “exhibit an approximately 20% increase in median survival”

    Animalsshown by hypomorphic mTOR(Δ/Δ) alleles with about 25% of wild-type expressionhypomorphic allele

    Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression

    Cell reports

Senescence-associated secretory phenotype (SASP)

mediatesin cells1upin human cells1mediatesin reviews1

3 studies
  1. MTOR mediates senescence-associated secretory phenotype (SASP) (as described in the review's mechanistic overview).

    “the cGAS-STING and mTOR-driven SASP programs”

    Reviewas described in the review's mechanistic overview

    Multidimensional Regulatory Network of Cellular Senescence: From Mechanisms to Theranostics

    ACS biomaterials science & engineering

  2. MTOR increases senescence-associated secretory phenotype (SASP) in human cells (shown by inhibition in OSKM-expressing primary human fibroblasts).

    “inhibition of mTOR blunts the senescence-associated secretory phenotype (SASP)”

    Cellsshown by inhibition in OSKM-expressing primary human fibroblasts

    Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence

    Genes & development

  3. MTOR mediates senescence-associated secretory phenotype (SASP) in cells (via 4EBP1-dependent translation of MAPKAPK2).

    “Here we report a mechanism by which mTOR controls the SASP by differentially regulating the translation of the MK2”

    Cellsvia 4EBP1-dependent translation of MAPKAPK2

    mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

    Nature cell biology

More on Senescence-associated secretory phenotype (SASP)

TP53

upin human cells1upin mouse cells1

2 studies
  1. MTOR activates TP53 in human cells within enlarged late endosomal aggregates after cortactin depletion.

    “The mTOR protein complex was accumulated and activated within these abnormal vesicular structures, leading to robust p53 activation”

    Cellswithin enlarged late endosomal aggregates after cortactin depletion

    Cortactin regulates metastatic dormancy of circulating tumor cells by suppressing mTOR-dependent senescence

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  2. MTOR activates TP53 in mouse cells (phosphorylation at serine 15).

    “mTOR kinase, a major component of mTORC1 and mTORC2, directly binds p53 and phosphorylates it at serine 15.”

    Cellsphosphorylation at serine 15

    mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53

    Oncogene

More on TP53

Bone mineral density

downin humans1OR 0.813–0.934

1 study
  1. MTOR is linked with lower bone mineral density in humans (OR 0.8130-0.9340).

    “increased genetically proxied mTOR expression in blood was associated with reduced BMD (OR = 0.8130-0.9340)”

    Humanssummary data-based Mendelian randomization using blood cis-eQTL instruments; except individuals younger than 30 yearsblood

    Mendelian Randomization Revealed Potential of mTOR Inhibitors for Treatment of Osteoporosis: Evidence From GWAS and Transcriptome Data

    International journal of endocrinology

More on Bone mineral density

Ovariectomy-induced bone loss

downin mice1

1 study
  1. MTOR protects against ovariectomy-induced bone loss in mice (ovariectomy; shown by X/A-like cell-specific Mtor deletion).

    “X/A-like cell-specific Mtor deletion significantly exacerbated bone loss in female mice following ovariectomy, impacting both trabecular and cortical parameters”

    Animalsovariectomy; shown by X/A-like cell-specific Mtor deletionfemales

    Intact mTOR signaling in gastric X/A-like cells is required for bone homeostasis

    Frontiers in endocrinology

Cortical bone mass

upin mice1

1 study
  1. MTOR increases cortical bone mass in mice (shown by X/A-like cell-specific Mtor deletion).

    “mTOR signaling deficiency in X/A-like cells compromises bone health in male mice, evidenced by cortical bone loss at 12 weeks”

    Animalsshown by X/A-like cell-specific Mtor deletionmales

    Intact mTOR signaling in gastric X/A-like cells is required for bone homeostasis

    Frontiers in endocrinology

Normal liver physiology

is required forin reviews1

1 study
  1. MTOR is required for normal liver physiology.

    “which is essential for normal liver physiology”

    Reviewliver

    Mammalian target of rapamycin in chronic liver disease and the potential for therapeutic manipulation

    Experimental gerontology

Hemostasis

no changein mice1

1 study
  1. MTOR showed no clear effect on hemostasis in mice (shown by knockout).

    “the absence of platelet mTOR did not impact hemostasis, inflammatory bleeding in the lung and skin, or FeCl3-induced arterial thrombosis”

    Animalsshown by knockout

    Platelet mTOR Is a Regulator of Sterile Immunothrombosis

    Arteriosclerosis, thrombosis, and vascular biology

All 66

Upstream

9

AMPK signaling

downin reviews2

2 studies
  1. AMPK signaling inhibits MTOR.

    “AMPK contributes to metabolic homeostasis through the inhibition of mTOR signaling”

    Review

    Regulatory Interplay of p53, AMPK, and mTOR in Decidualization: Implications for Reproductive Competence and Cancer Biology

    Reproductive sciences (Thousand Oaks, Calif.)

  2. AMPK signaling inhibits MTOR.

    “AMPK also suppresses mTOR, reducing age-related dysfunction.”

    Review

    Molecular Mechanisms of Cellular Senescence in Age-Related Endometrial Dysfunction

    Cells

More on AMPK signaling

STAU1

upin human cells1upin mice1

1 study
  1. STAU1 increases MTOR in mice (shown by STAU1 reduction in BAC-C9ORF72, ATXN2Q127 and Thy1-TDP-43 transgenic mice).

    “Reducing STAU1 levels in these mice normalized mTOR levels and activity and autophagy-related marker proteins.”

    Animalsshown by STAU1 reduction in BAC-C9ORF72, ATXN2Q127 and Thy1-TDP-43 transgenic mice

    Staufen Impairs Autophagy in Neurodegeneration

    Annals of neurology

  2. STAU1 increases MTOR in human cells (overexpression in HEK293 cells).

    “Overexpression of STAU1 in HEK293 cells increased mTOR levels through direct MTOR mRNA interaction, activating downstream targets and impairing autophagic flux.”

    Cellsoverexpression in HEK293 cells

    Staufen Impairs Autophagy in Neurodegeneration

    Annals of neurology

More on STAU1

RS4845987

downin humans1

1 study
  1. RS4845987 is linked with lower MTOR in humans.

    “reduces MTOR expression in T cells”

    HumansT cells

    Context-specific regulatory genetic variation in MTOR dampens neutrophil-T cell crosstalk in pneumonia-associated sepsis

    Nature communications

More on RS4845987

PPP4C

downin mice1

1 study
  1. PPP4C inhibits MTOR in mice (shown by PPP4 depletion).

    “depletion of PPP4 causes the abnormal activation of mTOR”

    Animalsshown by PPP4 depletionoocytefemales

    Protein phosphatase 4 maintains the survival of primordial follicles by regulating autophagy in oocytes

    Cell death & disease

More on PPP4C

p38γ/δ

upin mice1

1 study
  1. p38γ/δ activates MTOR in MKK6 knockout mice.

    “causing MKK3-p38γ/δ hyperphosphorylation and increased mammalian target of rapamycin (mTOR) signaling”

    Animalsin MKK6 knockout miceheart

    MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation

    eLife

BVR-A

downin mice1

1 study
  1. BVR-A inhibits MTOR in mice (shown by knockout (BVR-A−/− mice)).

    “BVR-A deficiency leads to the accumulation of oxidatively-damaged proteins along with mTOR hyper-activation in the cortex.”

    Animalsshown by knockout (BVR-A−/− mice)cerebral cortex

    BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain-Implications for Neurodegeneration

    Antioxidants (Basel, Switzerland)

More on BVR-A

MIR-199A-3P

downin cells1

1 study
  1. MIR-199A-3P inhibits MTOR in cells (direct target identified by target prediction and examination).

    “we identified mechanistic target of rapamycin kinase (mTOR) as a direct target of miR-199a-3p”

    Cellsdirect target identified by target prediction and examination

    miR-199a-3p regulates brown adipocyte differentiation through mTOR signaling pathway

    Molecular and cellular endocrinology

More on MIR-199A-3P

RHEB

downin reviews1

1 study
  1. RHEB inhibits MTOR (when not bound to GTP).

    “suggesting that RHEB can function as an inhibitor of mTOR when not bound to GTP”

    Reviewwhen not bound to GTP

    Small GTPases in C. elegans metabolism

    Small GTPases

More on RHEB

Old tissue

upin mice1

1 study
  1. Old tissue increases MTOR in mice (old compared with young and adult mice).

    “Significant increased mTOR protein levels were determined in old tissue and cells.”

    Animalsold compared with young and adult mice

    Macroautophagy is impaired in old murine brain tissue as well as in senescent human fibroblasts

    Redox biology

Associations

29

Cellular senescence

mixedin reviews2

2 studies
  1. MTOR is associated with cellular senescence.

    “While mechanistic target of rapamycin complex 1 is considered the master regulator of autophagy, it also influences senescence.”

    Review

    Orchestration of Autophagy and Senescence: Kinases Take the Center Stage

    Cells

  2. MTOR is associated with cellular senescence.

    “link mTOR to various processes related to aging, such as nutrient sensing, maintenance of proteostasis, autophagy, mitochondrial dysfunction, cellular senescence, and decline in stem cell function”

    Review

    mTOR as a central regulator of lifespan and aging

    F1000Research

More on Cellular senescence

Neurodegenerative disease

upin reviews1mixedin reviews1

2 studies
  1. MTOR is associated with neurodegenerative disease.

    “its imbalance is linked with a variety of neurodegenerative diseases”

    Reviewbrain

    mTOR/α-ketoglutarate-mediated signaling pathways in the context of brain neurodegeneration and neuroprotection

    BBA advances

  2. MTOR is associated with neurodegenerative disease.

    “mTOR forms the complexes mTOR Complex 1 and mTOR Complex 2 and can impact multiple neurodegenerative disorders that include Alzheimer's disease, Huntington's disease, and Parkinson's disease.”

    Review

    The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders

    Biochemical Society transactions

More on Neurodegenerative disease

Alzheimer's disease

upin humans1mixedin humans1

2 studies
  1. MTOR is associated with Alzheimer's disease in humans (aberrant mTOR activity in AD brains and rodent models).

    “aberrant mTOR activity is one of the key events contributing to the onset and progression of AD hallmarks”

    Reviewaberrant mTOR activity in AD brains and rodent modelsbrain

    mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis

    Neurochemistry international

  2. MTOR is associated with Alzheimer's disease in humans.

    “Aberrant regulation of mTOR occurs in the brains of patients with Alzheimer's disease and in numerous tissues of individuals with type 2 diabetes”

    Reviewbrain

    Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes

    Advances in experimental medicine and biology

More on Alzheimer's disease

Lifespan

upin mice1mixedin reviews1

2 studies
  1. MTOR is associated with lifespan.

    “the involvement of the mTOR pathway in regulating life span and aging has been studied extensively in the last decade”

    Review

    mTOR as a central regulator of lifespan and aging

    F1000Research

  2. MTOR is associated with lifespan in mice (Shown by mTOR mutation; mortality parameter changes differed in direction between sexes).

    “p53 mutation in Drosophila and mTOR mutation in mice caused increased median life span”

    AnimalsShown by mTOR mutation; mortality parameter changes differed in direction between sexes

    Multiple Metazoan Life-span Interventions Exhibit a Sex-specific Strehler-Mildvan Inverse Relationship Between Initial Mortality Rate and Age-dependent Mortality Rate Acceleration

    The journals of gerontology. Series A, Biological sciences and medical sciences

Generalized lymphatic anomaly

upin humans1

1 study
  1. MTOR is associated with generalized lymphatic anomaly in humans (lymphatic lesion tissue).

    “by immunohistochemical analysis, we documented altered expression of mTOR and its well-characterized downstream substrates”

    Humanslymphatic lesion tissuelymphatic lesion

    Targeting PI3K/AKT/mTOR Pathway Exerts Inhibitory Effects on Endothelial Cells from Generalized Lymphatic Anomaly

    Cells

More on Generalized lymphatic anomaly

Highly ranked bridge position between aging and longevity seed sets

upin silico1

1 study
  1. MTOR is associated with highly ranked bridge position between aging and longevity seed sets in silico (Aging-KG network topology).

    “Network analyses of the Aging-KG identified TP53, mTOR, and SIRT1 as highly ranked bridge candidates between aging and longevity seed sets.”

    In silicoAging-KG network topology

    A systems-level dissection of aging and longevity mechanisms powered by an evidence-routed AI knowledge graph

    Scientific reports

Pentadecanoic acid

downin reviews1

1 study
  1. Pentadecanoic acid is associated with MTOR (binding energy -4.4 kcal/mol versus -10.1 kcal/mol for rapamycin).

    “pentadecanoic acid binds within the active site with a binding energy of -4.4 kcal/mol”

    Reviewin molecular docking against the mTOR kinase domain (PDB 4JSV); weaker than rapamycin (-10.1 kcal/mol)

    Pentadecanoic acid as a potential endogenous mTOR modulator for age-related female infertility: Mechanistic insights, molecular docking evidence, and therapeutic perspectives

    The Journal of steroid biochemistry and molecular biology

More on Pentadecanoic acid

Basal metabolic rate

downin humans1

1 study
  1. MTOR is associated with basal metabolic rate in humans (phenome-wide association study of mTOR-related genetic variants) (Beta = -16.769, FDR = 2.21E - 25).

    “PheWAS identified an association between mTOR and basal metabolic rate (Beta = -16.769, FDR = 2.21E - 25)”

    Humansphenome-wide association study of mTOR-related genetic variants

    Mendelian Randomization Revealed Potential of mTOR Inhibitors for Treatment of Osteoporosis: Evidence From GWAS and Transcriptome Data

    International journal of endocrinology

Chronic liver disease

no changein reviews1

1 study
  1. MTOR is associated with chronic liver disease.

    “is also implicated in the pathogenesis of CLD and hepatocellular carcinoma (HCC)”

    Reviewliver

    Mammalian target of rapamycin in chronic liver disease and the potential for therapeutic manipulation

    Experimental gerontology

More on Chronic liver disease

Venous thrombosis

upin mice1

1 study
  1. MTOR raises the risk of venous thrombosis in mice (shown by knockout).

    “platelet-specific mTOR knockout mice were protected from ischemic stroke brain injury and stasis-induced venous thrombosis”

    Animalsshown by knockout

    Platelet mTOR Is a Regulator of Sterile Immunothrombosis

    Arteriosclerosis, thrombosis, and vascular biology

More on Venous thrombosis

All 29

Funding

92 grants since 2016

National Institute on Aging$22.6MNational Cancer Institute$20.7MNational Heart, Lung, and Blood Institute$7.1M

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 25Jan 2026: 45Feb 2026: 32Mar 2026: 48Apr 2026: 25May 2026: 19Jun 2026: 23Jul 2026: 11Aug 2026: 14Sep 2026: 24Oct 2026: 22Nov 2026: 10298 papers in 12 months

See all 1,492 papers on MTOR